Cargando…
Treatment of severe covid-19 with interleukin 6 receptor inhibition
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978669/ https://www.ncbi.nlm.nih.gov/pubmed/36936584 http://dx.doi.org/10.1136/bmjmed-2022-000144 |
| _version_ | 1784899570674696192 |
|---|---|
| author | Rajasundaram, Skanda Burgess, Stephen Gill, Dipender |
| author_facet | Rajasundaram, Skanda Burgess, Stephen Gill, Dipender |
| author_sort | Rajasundaram, Skanda |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9978669 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99786692023-03-16 Treatment of severe covid-19 with interleukin 6 receptor inhibition Rajasundaram, Skanda Burgess, Stephen Gill, Dipender BMJ Med Editorial BMJ Publishing Group 2022-03-02 /pmc/articles/PMC9978669/ /pubmed/36936584 http://dx.doi.org/10.1136/bmjmed-2022-000144 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Editorial Rajasundaram, Skanda Burgess, Stephen Gill, Dipender Treatment of severe covid-19 with interleukin 6 receptor inhibition |
| title | Treatment of severe covid-19 with interleukin 6 receptor inhibition |
| title_full | Treatment of severe covid-19 with interleukin 6 receptor inhibition |
| title_fullStr | Treatment of severe covid-19 with interleukin 6 receptor inhibition |
| title_full_unstemmed | Treatment of severe covid-19 with interleukin 6 receptor inhibition |
| title_short | Treatment of severe covid-19 with interleukin 6 receptor inhibition |
| title_sort | treatment of severe covid-19 with interleukin 6 receptor inhibition |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978669/ https://www.ncbi.nlm.nih.gov/pubmed/36936584 http://dx.doi.org/10.1136/bmjmed-2022-000144 |
| work_keys_str_mv | AT rajasundaramskanda treatmentofseverecovid19withinterleukin6receptorinhibition AT burgessstephen treatmentofseverecovid19withinterleukin6receptorinhibition AT gilldipender treatmentofseverecovid19withinterleukin6receptorinhibition |